GL Assessment

Cognistat is the leading cognitive test for assessing the five major cognitive ability areas: language, spatial skills, memory, calculations and reasoning. Cognistat was developed at Stanford University and is standardized for adolescents, adults and seniors (60 – 84). It can be administered by any suitably trained healthcare professional. The Cognistat assessment and screening test has been culturally adapted with clinical validity in many languages by collaborating with important universities, academic institutions and customers worldwide. With over 400 peer-reviewed scientific articles, Cognistat’s use in patients with stroke, dementia, traumatic brain injury, major psychiatric disorders and substance abuse is well documented. The Cognistat Assessment System preserves the strengths of the highly regarded paper and pencil version of Cognistat: Assesses five major areas of cognitive functioning, gives a quick yet comprehensive evaluation, utilizes a screen and metric approach.

CNS Vital Signs is a world leader in the design and development of neurocognitive and behavioral assessment tools and technologies. We provide clinicians and researchers with leading-edge technologies for improved neurocognitive and behavioral evaluation and management capabilities. Our platform offers broad-spectrum computerized neurocognitive testing to measure, monitor, and manage neurocognitive and behavioral health. Clinicians use CNS Vital Signs as a brief-core assessment to get a rapid or immediate read on a patient's neurocognitive status. The assessment platform is a well-established, commonly reimbursed method for evaluating patients who demonstrate neurocognitive or behavioral symptoms. CNS Vital Signs has been used for testing neurocognitive function by over 10,000 clinicians and researchers in 52 countries. Our platform provides solutions for hospitals, clinicians, and researchers to measure, monitor, and manage conditions.